Methamphetamine Activates Toll-Like Receptor 4 to Induce Central Immune Signaling within the Ventral Tegmental Area and Contributes to Extracellular Dopamine Increase in the Nucleus Accumbens Shell.
Methamphetamine Activates Toll-Like Receptor 4 to Induce Central Immune Signaling within the Ventral Tegmental Area and Contributes to Extracellular Dopamine Increase in the Nucleus Accumbens Shell.
复制标题
甲基苯丙胺激活 Toll 样受体 4,诱导腹侧被盖区内的中枢免疫信号传导,并有助于伏核壳中细胞外多巴胺的增加
DOI:
10.1021/acschemneuro.9b00225
复制
发表时间:
2019-08-21
影响因子:
5
通讯作者:
Watkins LR
中科院分区:
文献类型:
--
作者:
Wang X;Northcutt AL;Cochran TA;Zhang X;Fabisiak TJ;Haas ME;Amat J;Li H;Rice KC;Maier SF;Bachtell RK;Hutchinson MR;Watkins LR
Methamphetamine (METH) is a globally abused, highly addictive stimulant. While investigations of the rewarding and motivational effects of METH have focused on neuronal actions, increasing evidence suggests that METH can also target microglia, the innate immune cells of the central nervous system, causing release of proinflammatory mediators and therefore amplifying the reward changes in the neuronal activity induced by METH. However, how METH induces neuroinflammatory responses within the central nervous system (CNS) is unknown. Herein, we provide direct evidence that METH creates neuroinflammation, at least in part, via the activation of the innate immune Toll-like receptor 4 (TLR4). Biophysical studies revealed that METH bound to MD-2, the key co-receptor of TLR4. Molecular dynamics simulations showed METH binding stabilized the active heterotetramer (TLR4/MD-2)2 conformation. Classic TLR4 antagonists LPS-RS and TAK-242 attenuated METH induced NF-κB activation of microglia, whereas added MD-2 protein boosted METH-induced NF-κB activation. Systemically administered METH (1 mg/kg) was found to specifically up-regulate expression of both CD11b (microglial activation marker) and the proinflammatory cytokine interleukin 6 (IL-6) mRNAs in the ventral tegmental area (VTA), but not in either the nucleus accumbens shell (NAc) or prefrontal cortex (PFC). Systemic administration of a non-opioid, blood-brain barrier permeable TLR4 antagonist (+)-naloxone inhibited METH-induced activation of microglia and IL-6 mRNA over-expression in VTA. METH was found to increase conditioned place preference (CPP) as well as extracellular dopamine concentrations in the NAc, with both effects suppressed by the non-opioid TLR4 antagonist (+)-naloxone. Furthermore, intra-VTA injection of LPS-RS or IL-6 neutralizing antibody suppressed METH-induced elevation of extracellular NAc dopamine. Taken together, this series of studies demonstrate that METH-induced neuroinflammation is, at least in part, mediated by TLR4-IL6 signaling within the VTA, which has the downstream effect of elevating dopamine in the NAc shell. These results provide a novel understanding of the neurobiological mechanisms underlying acute METH reward that includes a critical role for central immune signaling, and offers a new target for medication development for treating drug abuse.
登录
查看更多内容
DOI:
10.1016/j.bbi.2017.08.012
发表时间:
2018-01
期刊:
Brain, behavior, and immunity
影响因子:
--
作者:
Brown KT;Levis SC;O'Neill CE;Northcutt AL;Fabisiak TJ;Watkins LR;Bachtell RK
通讯作者:
Bachtell RK
影响因子:
15.1
作者:
Hutchinson, Mark R.;Zhang, Yingning;Shridhar, Mitesh;Evans, John H.;Buchanan, Madison M.;Zhao, Tina X.;Slivka, Peter F.;Coats, Benjamen D.;Rezvani, Niloofar;Wieseler, Julie;Hughes, Travis S.;Landgraf, Kyle E.;Chan, Stefanie;Fong, Stephanie;Phipps, Simon;Falke, Joseph J.;Leinwand, Leslie A.;Maier, Steven F.;Yin, Hang;Rice, Kenner C.;Watkins, Linda R.
通讯作者:
Watkins, Linda R.
影响因子:
4.8
作者:
Du SH;Qiao DF;Chen CX;Chen S;Liu C;Lin Z;Wang H;Xie WB
通讯作者:
Xie WB
影响因子:
5.3
作者:
LaVoie, MJ;Card, JP;Hastings, TG
通讯作者:
Hastings, TG
影响因子:
4
作者:
Lewis, Susannah S.;Loram, Lisa C.;Hutchinson, Mark R.;Li, Chien-Ming;Zhang, Yingning;Maier, Steven F.;Huang, Yong;Rice, Kenner C.;Watkins, Linda R.
通讯作者:
Watkins, Linda R.